M.D. Ph.D. Hoyoung Huh - 14 Nov 2024 SCHEDULE 13G Report for Akari Therapeutics, Plc Ordinary Shares, $0.0001 par value (AKTX)

Filing Manager: M.D. Ph.D. Hoyoung Huh
Reporting Manager: Hoyoung Huh, M.D., Ph.D.
Security: Akari Therapeutics, Plc Ordinary Shares, $0.0001 par value
Symbol: AKTX
Shares outstanding: 53,512,954,839 shares
Disclosed Ownership: 8,294,508,000 shares
Ownership: 16%
Form type: SCHEDULE 13G
Filing time: 14 Feb 2025, 17:00:04 UTC
Date of event: 14 Nov 2024
Next filing: 04 Mar 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Hoyoung Huh, M.D., Ph.D.	16%	8,294,508,000	8,294,508,000	0	/s/ Hoyoung Huh	Authorized Person